{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:00:26Z","timestamp":1772164826735,"version":"3.50.1"},"reference-count":24,"publisher":"American Association for Cancer Research (AACR)","issue":"12","license":[{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"vor","delay-in-days":16,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["23ama221424h0001\/24ama221424h0002"],"award-info":[{"award-number":["23ama221424h0001\/24ama221424h0002"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007533","name":"Kobayashi Foundation for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007533","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>KRAS proto-oncogene, GTPase (KRAS)-liver kinase B1 (LKB1)\u2013mutant (KL) non\u2013small cell lung cancer (NSCLC), characterized by a profoundly immunosuppressive tumor microenvironment (TME), is highly resistant to immune checkpoint inhibitors. Despite their high tumor mutation burden, KL tumors exhibit low expression of PD-L1, reduced immune cell infiltration, and suppressed immune signaling pathways. Systematic genome analyses revealed that LKB1 loss suppresses dipeptidyl peptidase 4 (DPP4) expression and activity in KRAS-mutant lung cancer. The therapeutic potential of restoring DPP4 function to improve the immune response in KL lung cancer was evaluated using patient-derived tumor samples and syngeneic mouse models. Restoration of DPP4 expression reprogrammed the TME and significantly increased immune-related gene signatures, including those involved in T-cell migration and NK-cell activation. Restoration of DPP4 expression in three-dimensional microfluidic models enhanced NK-cell chemotaxis and spheroid-targeting activity. Furthermore, DPP4 restoration was synergized with anti\u2013PD-1 therapy to achieve significant tumor regression in syngeneic KL murine models. These findings suggest that LKB1 loss suppresses DPP4 expression, contributing to the immunosuppressive characteristics of the TME in KL-NSCLC cells, whereas restoring DPP4 expression promotes NK-cell recruitment, facilitates immune activation, and enhances the effects of anti\u2013PD-1 therapy. These results suggest that DPP4 is a key immune modulator and a promising therapeutic target, providing a novel strategy to overcome immune resistance and improve immunotherapy outcomes in this challenging subset of lung cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>LKB1 loss suppresses DPP4 expression in KL-NSCLC; however, restoring DPP4 expression in vitro promotes NK-cell recruitment, mitigating the immunosuppressive TME and enhancing the efficacy of anti\u2013PD-1 therapy in KL models.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-25-0199","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T16:09:54Z","timestamp":1764000594000},"page":"2175-2185","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dipeptidyl Peptidase 4 Restoration Facilitates Antitumor Immunity in KRAS-LKB1\u2013Mutant Lung Cancer"],"prefix":"10.1158","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-1209-661X","authenticated-orcid":false,"given":"Toshiyuki","family":"Tenma","sequence":"first","affiliation":[{"name":"1Division of Respiratory Medicine and Neurology, Department of Internal Medicine, Asahikawa Medical University, Asahikawa, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2959-9972","authenticated-orcid":false,"given":"Ryohei","family":"Yoshida","sequence":"additional","affiliation":[{"name":"1Division of Respiratory Medicine and Neurology, Department of Internal Medicine, Asahikawa Medical University, Asahikawa, Japan."},{"name":"2Clinical Research Center, Keiyukai Yoshida Hospital, Asahikawa, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9915-554X","authenticated-orcid":false,"given":"Hiraku","family":"Yanada","sequence":"additional","affiliation":[{"name":"1Division of Respiratory Medicine and Neurology, Department of Internal Medicine, Asahikawa Medical University, Asahikawa, Japan."},{"name":"2Clinical Research Center, Keiyukai Yoshida Hospital, Asahikawa, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8653-7593","authenticated-orcid":false,"given":"Kiichi","family":"Nitanai","sequence":"additional","affiliation":[{"name":"1Division of Respiratory Medicine and Neurology, Department of Internal Medicine, Asahikawa Medical University, Asahikawa, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8326-8296","authenticated-orcid":false,"given":"Toshihiro","family":"Nagato","sequence":"additional","affiliation":[{"name":"3Department of Pathology, Asahikawa Medical University, Asahikawa, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8478-4417","authenticated-orcid":false,"given":"Kyohei","family":"Oyama","sequence":"additional","affiliation":[{"name":"4Department of Cardiac Surgery, Asahikawa Medical University, Asahikawa, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4336-588X","authenticated-orcid":false,"given":"Nobunari","family":"Sasaki","sequence":"additional","affiliation":[{"name":"5Project for Cancer Immunotherapy Development, Cancer Precision Medicine Center, Japanese Foundation for Cancer Research, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1747-4028","authenticated-orcid":false,"given":"Mizuki","family":"Homme","sequence":"additional","affiliation":[{"name":"5Project for Cancer Immunotherapy Development, Cancer Precision Medicine Center, Japanese Foundation for Cancer Research, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4398-1086","authenticated-orcid":false,"given":"Chie","family":"Mori","sequence":"additional","affiliation":[{"name":"1Division of Respiratory Medicine and Neurology, Department of Internal Medicine, Asahikawa Medical University, Asahikawa, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6889-7809","authenticated-orcid":false,"given":"Takayuki","family":"Ohkuri","sequence":"additional","affiliation":[{"name":"3Department of Pathology, Asahikawa Medical University, Asahikawa, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8385-5386","authenticated-orcid":false,"given":"Yusuke","family":"Ono","sequence":"additional","affiliation":[{"name":"6Institute of Biomedical Research, Sapporo Higashi Tokushukai Hospital, Sapporo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2126-6938","authenticated-orcid":false,"given":"Shoichiro","family":"Tange","sequence":"additional","affiliation":[{"name":"7Department of Medical Genome Sciences, Cancer Research Institute, Sapporo Medical University School of Medicine, Sapporo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5368-0527","authenticated-orcid":false,"given":"Yoshinori","family":"Minami","sequence":"additional","affiliation":[{"name":"1Division of Respiratory Medicine and Neurology, Department of Internal Medicine, Asahikawa Medical University, Asahikawa, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5222-8961","authenticated-orcid":false,"given":"Hiroya","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"3Department of Pathology, Asahikawa Medical University, Asahikawa, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1068-7024","authenticated-orcid":false,"given":"Yusuke","family":"Mizukami","sequence":"additional","affiliation":[{"name":"6Institute of Biomedical Research, Sapporo Higashi Tokushukai Hospital, Sapporo, Japan."},{"name":"8Division of Gastroenterology, Department of Medicine, Asahikawa Medical University, Asahikawa, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5422-4275","authenticated-orcid":false,"given":"David A.","family":"Barbie","sequence":"additional","affiliation":[{"name":"9Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6532-2543","authenticated-orcid":false,"given":"Shunsuke","family":"Kitajima","sequence":"additional","affiliation":[{"name":"5Project for Cancer Immunotherapy Development, Cancer Precision Medicine Center, Japanese Foundation for Cancer Research, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6505-8786","authenticated-orcid":false,"given":"Takaaki","family":"Sasaki","sequence":"additional","affiliation":[{"name":"1Division of Respiratory Medicine and Neurology, Department of Internal Medicine, Asahikawa Medical University, Asahikawa, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1086","published-online":{"date-parts":[[2025,12,17]]},"reference":[{"key":"2025121701050115100_bib1","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1200\/JCO.21.01497","article-title":"First-line immunotherapy for non-small-cell lung cancer","volume":"40","author":"Reck","year":"2022","journal-title":"J Clin Oncol"},{"key":"2025121701050115100_bib2","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41591-019-0382-x","article-title":"Genomic correlates of response to immune checkpoint blockade","volume":"25","author":"Keenan","year":"2019","journal-title":"Nat Med"},{"key":"2025121701050115100_bib3","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1158\/1078-0432.CCR-17-1841","article-title":"Effects of co-occurring genomic alterations on outcomes in patients with KRAS-mutant non-small cell lung cancer","volume":"24","author":"Arbour","year":"2018","journal-title":"Clin Cancer Res"},{"key":"2025121701050115100_bib4","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1158\/2159-8290.CD-18-0099","article-title":"STK11\/LKB1 mutations and PD-1 inhibitor resistance in KRAS-mutant lung adenocarcinoma","volume":"8","author":"Skoulidis","year":"2018","journal-title":"Cancer Discov"},{"key":"2025121701050115100_bib5","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1158\/0008-5472.CAN-15-1439","article-title":"STK11\/LKB1 deficiency promotes neutrophil recruitment and proinflammatory cytokine production to suppress T-cell activity in the lung tumor microenvironment","volume":"76","author":"Koyama","year":"2016","journal-title":"Cancer Res"},{"key":"2025121701050115100_bib6","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1158\/2159-8290.CD-14-1236","article-title":"Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilities","volume":"5","author":"Skoulidis","year":"2015","journal-title":"Cancer Discov"},{"key":"2025121701050115100_bib7","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1158\/2159-8290.CD-18-0689","article-title":"Suppression of STING associated with LKB1 loss in KRAS-driven lung cancer","volume":"9","author":"Kitajima","year":"2019","journal-title":"Cancer Discov"},{"key":"2025121701050115100_bib8","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.ccell.2022.08.015","article-title":"MPS1 inhibition primes immunogenicity of KRAS-LKB1 mutant lung cancer","volume":"40","author":"Kitajima","year":"2022","journal-title":"Cancer Cell"},{"key":"2025121701050115100_bib9","doi-asserted-by":"crossref","first-page":"5194","DOI":"10.3390\/cancers14215194","article-title":"CD26 and cancer","volume":"14","author":"Cordero","year":"2022","journal-title":"Cancers (Basel)"},{"key":"2025121701050115100_bib10","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ccell.2018.08.009","article-title":"Overcoming resistance to dual innate immune and MEK inhibition downstream of KRAS","volume":"34","author":"Kitajima","year":"2018","journal-title":"Cancer Cell"},{"key":"2025121701050115100_bib11","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.annonc.2023.04.005","article-title":"Machine learning-based immune phenotypes correlate with STK11\/KEAP1 co-mutations and prognosis in resectable NSCLC: a sub-study of the TNM-I trial","volume":"34","author":"Rakaee","year":"2023","journal-title":"Ann Oncol"},{"key":"2025121701050115100_bib12","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1126\/science.8101391","article-title":"Direct association of adenosine deaminase with a T cell activation antigen, CD26","volume":"261","author":"Kameoka","year":"1993","journal-title":"Science"},{"key":"2025121701050115100_bib13","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/0167-5699(94)90316-6","article-title":"CD26: a surface protease involved in T-cell activation","volume":"15","author":"Fleischer","year":"1994","journal-title":"Immunol Today"},{"key":"2025121701050115100_bib14","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/carcin\/bgz009","article-title":"The CD26\/DPP4-inhibitor vildagliptin suppresses lung cancer growth via macrophage-mediated NK cell activity","volume":"40","author":"Jang","year":"2019","journal-title":"Carcinogenesis"},{"key":"2025121701050115100_bib15","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/ni.3201","article-title":"Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy","volume":"16","author":"Barreira da Silva","year":"2015","journal-title":"Nat Immunol"},{"key":"2025121701050115100_bib16","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1007\/s12094-023-03187-5","article-title":"Dipeptidyl peptidase 4 inhibitor reduces tumor-associated macrophages and enhances anti-PD-L1-mediated tumor suppression in non-small cell lung cancer","volume":"25","author":"Zuo","year":"2023","journal-title":"Clin Transl Oncol"},{"key":"2025121701050115100_bib17","doi-asserted-by":"crossref","first-page":"1258637","DOI":"10.3389\/fimmu.2023.1258637","article-title":"Adenosine, bridging chronic inflammation and tumor growth","volume":"14","author":"Chen","year":"2023","journal-title":"Front Immunol"},{"key":"2025121701050115100_bib18","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ccell.2018.01.011","article-title":"Fibroblast heterogeneity and immunosuppressive environment in human breast cancer","volume":"33","author":"Costa","year":"2018","journal-title":"Cancer Cell"},{"key":"2025121701050115100_bib19","doi-asserted-by":"crossref","first-page":"155340","DOI":"10.1016\/j.metabol.2022.155340","article-title":"Nonenzymatic function of DPP4 promotes diabetes-associated cognitive dysfunction through IGF-2R\/PKA\/SP1\/ERp29\/IP3R2 pathway-mediated impairment of Treg function and M1 microglia polarization","volume":"138","author":"Hui","year":"2023","journal-title":"Metabolism"},{"key":"2025121701050115100_bib20","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/s41586-024-07943-7","article-title":"CTLA4 blockade abrogates KEAP1\/STK11-related resistance to PD-(L)1 inhibitors","volume":"635","author":"Skoulidis","year":"2024","journal-title":"Nature"},{"key":"2025121701050115100_bib21","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1158\/0008-5472.CAN-18-3527","article-title":"LKB1 and KEAP1\/NRF2 pathways cooperatively promote metabolic reprogramming with enhanced glutamine dependence in KRAS-mutant lung adenocarcinoma","volume":"79","author":"Galan-Cobo","year":"2019","journal-title":"Cancer Res"},{"key":"2025121701050115100_bib22","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1158\/1078-0432.CCR-20-2859","article-title":"STK11\/LKB1 mutations in NSCLC are associated with KEAP1\/NRF2-dependent radiotherapy resistance targetable by glutaminase inhibition","volume":"27","author":"Sitthideatphaiboon","year":"2021","journal-title":"Clin Cancer Res"},{"key":"2025121701050115100_bib23","doi-asserted-by":"crossref","first-page":"108444","DOI":"10.1016\/j.celrep.2020.108444","article-title":"Concurrent mutations in STK11 and KEAP1 promote ferroptosis protection and SCD1 dependence in lung cancer","volume":"33","author":"Wohlhieter","year":"2020","journal-title":"Cell Rep"},{"key":"2025121701050115100_bib24","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.3390\/cancers16132427","article-title":"Soluble CD26: from suggested biomarker for cancer diagnosis to plausible marker for dynamic monitoring of immunotherapy","volume":"16","author":"Kotrulev","year":"2024","journal-title":"Cancers (Basel)"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-25-0199\/3684683\/crc-25-0199.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/5\/12\/2175\/3715944\/crc-25-0199.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/5\/12\/2175\/3715944\/crc-25-0199.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T06:05:11Z","timestamp":1765951511000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/5\/12\/2175\/770976\/Dipeptidyl-Peptidase-4-Restoration-Facilitates"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":24,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-25-0199","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/2767-9764.c.8206936","asserted-by":"object"}],"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2767-9764.30900343","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30900364","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30900352","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30900340","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30900358","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30900346","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30900355","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30900349","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.30900361","asserted-by":"object"}]},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,1]]}}}